,outcome,arm 1,arm 2
0,intervention,P600,P900
0,,47 patients,45 patients
0,median times to tumor progression,4.2,4.6 months
0,stable disease,50 %,50 %
0,response rates,"17.0 % ( 95 % confidence interval , 7.7-30.8 % )","15.6 % ( 95 % confidence interval , 6.5-29.5 % )"
0,median progression-free survival,4.2,4.1 months
